Michael Ellow Sells Synopsys Shares

Synopsys CRO Michael Ellow sold 2,543 shares on June 15, 2026.

Written by EarningsIQ · Published Jun 16, 2026, 6:01 PM EDT · Updated Jun 16, 2026, 7:01 PM EDT

Key Points

Michael Ellow, Chief Revenue Officer of Synopsys, sold 2,543 shares on June 15, 2026.
Synopsys, Inc. is trading at $454.38 with a market cap of $87 billion and a P/E ratio of 104.2.
Analysts maintain a 'buy' consensus with a mean target price of $560.38, based on 26 opinions.

On June 15, 2026, Michael Ellow, the Chief Revenue Officer of Synopsys, Inc. (NasdaqGS: SNPS), sold 2,543 shares of the company. The sale was made at the market price of $454.38 per share. This transaction was not part of a pre-planned trading program.

Insider Buying and Selling at Synopsys, Inc.

Michael Ellow's recent sale of 2,543 shares on June 15, 2026, was part of a series of insider transactions at Synopsys. Other notable transactions on the same day include Kankanwadi Sudhindra, the Deputy CFO & CAO, buying 720 shares and selling 249 shares, and Ghazi Sassine, the President and CEO, selling 14,603 shares. These transactions were not under any pre-planned trading arrangements.

Synopsys, Inc. Stock Snapshot

Shares of Synopsys, Inc. (NasdaqGS: SNPS) are currently trading at $454.38. The company boasts a market capitalization of approximately $87 billion, with a P/E ratio of 104.2 and a forward P/E of 26.3. Synopsys has a 52-week trading range between $376.18 and $651.73. The 50-day moving average is $476.05, and the 200-day moving average stands at $461.68. The company's beta is 1.214, indicating a moderate level of volatility compared to the market.

Recent Earnings

Synopsys reported revenues of $8.68 billion, reflecting a growth rate of 41.9%. The company's net margin is 8.9%, and it achieved a return on equity of 3.8%. The next earnings report is scheduled for September 8, 2026.

Analysts Set New Price Targets

Several analysts have recently maintained their ratings on Synopsys. On May 28, 2026, Citigroup maintained a 'buy' rating with a price target of $610. BNP Paribas kept a 'sell' rating with a target of $450, while Stifel and B of A Securities both maintained 'buy' ratings with targets of $600. The consensus among analysts is a 'buy', with a mean target price of $560.38, based on 26 analyst opinions.

About Synopsys, Inc.

Synopsys, Inc. is a leading technology company based in Sunnyvale, California. It specializes in providing design IP solutions for the semiconductor and electronics industries. The company operates through two main segments: Design Automation and Design IP. Its offerings include digital and custom IC design solutions, verification solutions, and FPGA design products, among others. Synopsys also collaborates with Arm Holdings to develop advanced CPU solutions. Led by CEO Sassine Ghazi, the company employs around 28,000 people.

Bottom Line

Michael Ellow's recent sale of Synopsys shares is part of routine insider trading activity. Investors often track such transactions for insights, but it's important to remember that this information is backward-looking and may not reflect current positions. Synopsys continues to be a strong player in the technology sector, with analysts maintaining a positive outlook on its stock.